增加蔬菜攝入量不能降低早期前列腺癌患者疾病進(jìn)展的風(fēng)險(xiǎn)
2020-01-16
來(lái)源：小柯機(jī)器人
美國(guó)加州大學(xué)圣地亞哥摩爾綜合癌癥中心J. Kellogg Parsons聯(lián)合羅斯韋爾公園綜合癌癥中心James Marshall課題組取得一項(xiàng)新突破。他們分析了增加蔬菜攝入的行為干預(yù)對(duì)早期前列腺癌患者癌癥進(jìn)展的影響。相關(guān)論文2020年1月14日發(fā)表在《美國(guó)醫(yī)學(xué)會(huì)雜志》上。
基于專(zhuān)家意見(jiàn)、臨床前研究和觀察數(shù)據(jù)制定的指南，鼓勵(lì)前列腺癌幸存者多吃蔬菜以改善預(yù)后。
為了確定增加蔬菜攝入量對(duì)早期前列腺癌患者癌癥進(jìn)展的影響，2011年1月至2017年8月，研究組在美國(guó)的91家泌尿外科和腫瘤內(nèi)科診所進(jìn)行了一項(xiàng)隨機(jī)臨床試驗(yàn)，共招募了478名50-80歲的男性，均經(jīng)活檢證實(shí)為前列腺癌，cT2a期及以下，血清前列腺特異性抗原（PSA）水平低于10ng/mL。將這些患者按1：1隨機(jī)分組，其中膳食干預(yù)組237名，研究組每天給患者打電話，敦促其保證每日食用7種以上蔬菜；對(duì)照組241名，僅給予關(guān)于飲食和前列腺癌的書(shū)面材料。
478名患者的平均年齡為64歲，平均PSA水平為4.9ng/mL，有443名患者納入主要分析。共有245名患者疾病進(jìn)展，其中干預(yù)組124名，對(duì)照組121名，兩組的進(jìn)展時(shí)間無(wú)顯著差異。干預(yù)組和對(duì)照組24個(gè)月的K-M無(wú)進(jìn)展百分比分別為43.5%和41.4%。
研究結(jié)果表明，在接受積極檢測(cè)的早期前列腺癌患者中，增加蔬菜攝入量的行為干預(yù)并未顯著降低前列腺癌進(jìn)展的風(fēng)險(xiǎn)。研究結(jié)果不支持前列腺癌患者多吃蔬菜來(lái)改善預(yù)后。
附：英文原文
Title: Effect of a Behavioral Intervention to Increase Vegetable Consumption on Cancer Progression Among Men With Early-Stage Prostate Cancer: The MEAL Randomized Clinical Trial
Author: J. Kellogg Parsons, David Zahrieh, James L. Mohler, Electra Paskett, Donna E. Hansel, Adam S. Kibel, Heshan Liu, Drew K. Seisler, Loki Natarajan, Martha White, Olwen Hahn, John Taylor, Sheri J. Hartman, Sean P. Stroup, Peter Van Veldhuizen, Lannis Hall, Eric J. Small, Michael J. Morris, John P. Pierce, James Marshall
Issue&Volume: 2020/01/14
Abstract:
Importance Guidelines endorsing vegetable-enriched diets to improve outcomes for prostate cancer survivors are based on expert opinion, preclinical studies, and observational data.
Objective To determine the effect of a behavioral intervention that increased vegetable intake on cancer progression in men with early-stage prostate cancer.
Design, Setting, and Participants The Men’s Eating and Living (MEAL) Study (CALGB 70807 [Alliance]) was a randomized clinical trial conducted at 91 US urology and medical oncology clinics that enrolled 478 men aged 50 to 80 years with biopsy-proven prostate adenocarcinoma (International Society of Urological Pathology grade group?=?1 in those <70 years and ≤2 in those ≥70 years), stage cT2a or less, and serum prostate-specific antigen (PSA) level less than 10 ng/mL. Enrollment occurred from January 2011 to August 2015; 24-month follow-up occurred from January 2013 to August 2017.
Interventions Patients were randomized to a counseling behavioral intervention by telephone promoting consumption of 7 or more daily vegetable servings (MEAL intervention; n?=?237) or a control group, which received written information about diet and prostate cancer (n?=?241).
Main Outcomes and Measures The primary outcome was time to progression; progression was defined as PSA level of 10 ng/mL or greater, PSA doubling time of less than 3 years, or upgrading (defined as increase in tumor volume or grade) on follow-up prostate biopsy.
Results Among 478 patients randomized (mean [SD] age, 64 [7] years; mean [SD] PSA level, 4.9 [2.1] ng/mL), 443 eligible patients (93%) were included in the primary analysis. There were 245 progression events (intervention: 124; control: 121). There were no significant differences in time to progression (unadjusted hazards ratio, 0.96 [95% CI, 0.75 to 1.24]; adjusted hazard ratio, 0.97 [95% CI, 0.76 to 1.25]). The 24-month Kaplan-Meier progression-free percentages were 43.5% [95% CI, 36.5% to 50.6%] and 41.4% [95% CI, 34.3% to 48.7%] for the intervention and control groups, respectively (difference, 2.1% [95% CI, ?8.1% to 12.2%]).
Conclusions and Relevance Among men with early-stage prostate cancer managed with active surveillance, a behavioral intervention that increased vegetable consumption did not significantly reduce the risk of prostate cancer progression. The findings do not support use of this intervention to decrease prostate cancer progression in this population, although the study may have been underpowered to identify a clinically important difference.
DOI: 10.1001/jama.2019.20207
Source: https://jamanetwork.com/journals/jama/article-abstract/2758598
聲明：本文版權(quán)歸原作者所有，轉(zhuǎn)載文章僅為傳播更多信息，如作者信息標(biāo)記有誤，或侵犯您的版權(quán)，請(qǐng)聯(lián)系我們，我們將在及時(shí)修改或刪除內(nèi)容，聯(lián)系郵箱：marketing@360worldcare.com
